Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Cardiovascular

Latest News

Latest Videos

Candidacy for Later-Line Cholesterol-Lowering Therapies

Candidacy for Later-Line Cholesterol-Lowering Therapies

Management of High-Risk Populations With Hyperlipidemia

Management of High-Risk Populations With Hyperlipidemia

Efficacy and Safety of PCSK9 Inhibitors

Efficacy and Safety of PCSK9 Inhibitors

Lipid Management: Coverage Criteria vs FDA Labeling

Lipid Management: Coverage Criteria vs FDA Labeling

Coverage of Statins/Nonstatins in Lipid Management

Coverage of Statins/Nonstatins in Lipid Management

Cholesterol Goals in Primary Cardiovascular Disease Prevention

Cholesterol Goals in Primary Cardiovascular Disease Prevention

Early Detection of Risk and Familial Hypercholesterolemia

Early Detection of Risk and Familial Hypercholesterolemia

Managed Care Decision Making in CVD and Lipid Control

Managed Care Decision Making in CVD and Lipid Control

Current CVD Prevention and Management Challenges

Current CVD Prevention and Management Challenges

Dr Janet Wright Discusses How Million Hearts Will Leverage Partnerships for Success

Dr Janet Wright Discusses How Million Hearts Will Leverage Partnerships for Success

More News

The Importance of Real-World Data in Type 2 Diabetes

May 30th 2017

Understanding the DUAL VII Findings in Type 2 Diabetes

May 30th 2017

Impact of Cardiovascular Data in Type 2 Diabetes

May 30th 2017

Access to Therapeutic Combinations in Type 2 Diabetes

May 30th 2017

Hypoglycemia: An Unrecognized Complication in Diabetes

May 30th 2017

Clinical Evidence of Insulin Degludec in Type 2 Diabetes

May 30th 2017

Formulary Access to Insulins in Type 2 Diabetes

May 30th 2017

Deciding Among Insulin Therapies for Type 2 Diabetes

May 30th 2017

Practical Decisions in Type 2 Diabetes

May 30th 2017

Barriers to Insulin Therapy in Type 2 Diabetes

May 30th 2017

Role of GLP-1/Insulin Combinations

May 30th 2017

Formulary Decisions and GLP-1/Insulin Combinations

May 30th 2017

Cardiovascular Considerations in Antidiabetic Therapies

May 30th 2017

Appropriate Access: Payer Perspective on Newer Insulins

May 30th 2017

Evidence With Ultra–Long Acting Insulins

May 30th 2017

Barriers to Traditional Insulin Therapy

May 30th 2017

Formulary Management: Antidiabetes Medications

May 30th 2017

Juggling Multiple Factors When Selecting Therapy

May 30th 2017

Adherence Matters When Weighing a Single Injection

May 30th 2017

The Advantages of Insulin, GLP-1 Combinations

May 30th 2017

Glycemic Control Is the Bottom Line

May 30th 2017

Formulary Decisions and Clinical Practice

May 30th 2017

Understanding Factors Behind Insulin Costs

May 30th 2017

Comparing New Insulins to Older Formulations

May 30th 2017

When to Start Insulin? Lack of Consensus on Targets

May 30th 2017

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Monoclonal Antibodies Had Varying Efficacy in Treating MG